Ceramides are central intermediates of sphingolipid metabolism, a family of fatty molecules that form membranes and act as signaling compounds. In mammals, elevated ceramide levels are closely associated with insulin resistance and type 2 diabetes, but the relationship is complicated by the fact that ceramides come in many molecular species with different fatty-acid chain lengths. Ceramide synthases, the enzymes that build ceramides, therefore sit at a critical control point. Unusually, several members of the ceramide synthase family carry a conserved homeodomain, a DNA-binding module best known from transcription factors, whose metabolic role has remained poorly understood.

The fruit fly offers a clean experimental system for probing this puzzle. Drosophila melanogaster possesses only one ceramide synthase gene, schlank, whose protein contains the catalytic Lag1p motif required for ceramide production as well as two predicted nuclear localization sequences, NLS1 and NLS2, embedded within the homeodomain region. Because there is just one enzyme rather than a family of six as in mammals, any change in its sequence can be interpreted without worrying about redundancy between related proteins masking the effect.

To test what each region does, the team used genome engineering to create knock-in flies carrying precise point mutations in the endogenous schlank gene. Two variants took center stage: KINLS1, which disrupts the first nuclear localization sequence, and KIE118A, which replaces a glutamic acid at position 118 with alanine. Under normal dietary conditions both mutants looked deceptively healthy. They retained DNA binding and the transcriptional repression activity characteristic of the wild-type protein, suggesting that the homeodomain’s day job was still being performed.

The picture changed dramatically when the flies were challenged with a high-sugar diet. Both knock-in lines became markedly more vulnerable to diet-induced metabolic dysfunction, developing enhanced hyperglycemia and showing impaired recruitment of tGPH, a fluorescent reporter used to visualize insulin signaling at the cell membrane. In other words, mutations that left the enzyme’s basal functions intact still compromised the animal’s ability to cope with sugar excess, revealing that the homeodomain contributes to metabolic stress tolerance in ways invisible under standard conditions.

The KIE118A mutant displayed additional defects that pointed to a breakdown in hormonal communication. These flies showed increased nuclear localization of FoxO, a transcription factor that acts as a readout of reduced insulin signaling, and retention of DILP2, one of the fly’s insulin-like peptides, inside the insulin-producing cells of the brain. Normally these cells release DILP2 into circulation to coordinate glucose handling across the body; its accumulation within the secreting cells suggests a failure in the release machinery or in the feedback loops that normally prompt secretion.

Remarkably, the direction of the effect could be reversed depending on which part of the protein was altered and where it was expressed. When the researchers used tissue-specific allele-switching to replace the fat body’s endogenous Schlank with a DNA-binding-deficient NLS2 variant or a catalytically inactive H215D variant, selected high-sugar-diet phenotypes were partially attenuated rather than worsened. FoxO nuclear accumulation and DILP2 retention both improved in these animals. However, the rescue was incomplete: hyperglycemia and reduced body weight persisted, indicating that the fat body is one node in a larger network rather than the sole site of action.

Lipidomic analysis by mass spectrometry uncovered the biochemical substrate of these effects. The sphingolipid profile of the flies underwent extensive remodeling in a diet-dependent manner, and the two fat-body variants, NLS2 and H215D, caused a marked reduction of the fat-body ceramide pool. This depletion extended across ceramide species containing the d14:1/20:0 and d14:1/22:0 fatty-acid combinations, as well as ceramide phosphoethanolamine and hexosylceramide, the sphingolipid classes that dominate insect membranes. The data link specific ceramide species, not just total ceramide mass, to the insulin phenotypes.

The study’s central conclusion is that the Schlank homeodomain regulates insulin homeostasis in a site- and tissue-dependent manner. Disrupting the nuclear localization sequence NLS1 or the conserved glutamate at position 118 increases susceptibility to diet-induced insulin resistance, while swapping in DNA-binding-deficient or catalytically inactive variants specifically in the fat body can partially shield the animal from some of the same phenotypes. The authors propose a model in which insulin signaling, inter-organ communication between the brain’s insulin-producing cells and the fat body, and the composition of the sphingolipid pool jointly determine metabolic outcome.

For researchers working on human metabolic disease, the implications are tantalizing. Mammalian ceramide synthases also carry homeodomain-like regions, and if a comparable nuclear function exists in human cells, it could represent an unexploited regulatory axis connecting lipid metabolism, gene expression and insulin sensitivity. The fly work cannot yet prescribe therapies, but it demonstrates with unusual clarity that the same enzyme can push metabolism toward resistance or toward resilience depending on which of its molecular addresses is altered, and that the fat body, the insect analog of adipose tissue and liver, is a decisive arena in which ceramide chemistry and insulin biology meet.

Subject of Research: How homeodomain sites of the Drosophila ceramide synthase Schlank differentially regulate diet-induced insulin resistance and sphingolipid metabolism

Article Title: Drosophila CerS homeodomain sites differentially alter insulin resistance

Article References: Vera-Granda, C., Sociale, M., Beckschäfer, K., Kanevskij, I., Gerding, M., Eckardt, F., Rindsfüsser, H., Thiele, C., Ziegler, A. B., Bülow, M. H., & Bauer, R. (2026). Drosophila CerS homeodomain sites differentially alter insulin resistance. BMC Biology. https://doi.org/10.1186/s12915-026-02763-9

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02763-9

Keywords: ceramide synthase, sphingolipids, insulin resistance, Drosophila melanogaster, homeodomain, high-sugar diet, fat body, DILP2, FoxO, lipidomics, type 2 diabetes, BMC Biology

The factor in question is DAF-16, the nematode worm Caenorhabditis elegans equivalent of the mammalian FOXO family of transcription factors. DAF-16 sits at the bottom of the insulin/IGF signalling pathway, a nutrient-sensing cascade whose reduction reliably extends lifespan across the animal kingdom. When insulin-like signals are low, DAF-16 accumulates in the nucleus and switches on batteries of genes involved in stress resistance, detoxification and metabolic remodelling. Because DNA repair is an energetically expensive undertaking, biologists have long suspected that it must be coordinated with the metabolic state of the cell, and the insulin pathway was an obvious candidate coordinator. What remained unclear was whether DAF-16 directly participates in maintaining genomic integrity or merely influences it indirectly through general stress physiology.

To answer that question, the team subjected worms with altered insulin signalling to genotoxic stress, including ionising radiation, and then measured how well the animals repaired the resulting lesions. The results were striking. Under conditions of reduced insulin/IGF signalling, when DAF-16 is active, the expression of DNA damage response repair genes was maintained at a higher level, and damaged DNA was repaired more promptly. Using chromatin immunoprecipitation-style approaches to examine promoter occupancy, the researchers found that activated DAF-16 binds directly to the regulatory regions of DDR genes, demonstrating that the transcription factor is not a passive bystander but an active, sequence-specific regulator of the repair programme.

This direct promoter binding is the mechanistic heart of the study. It means that when insulin signalling drops, DAF-16 enters the nucleus and physically parks itself on the genes encoding repair proteins, holding them in a state of readiness. Should a double-strand break or other lesion occur, the repair machinery is already being produced at elevated levels, allowing the cell to respond without the delay that would otherwise be required to ramp up gene expression from scratch. In effect, low insulin signalling pre-arms the genome’s emergency response, a configuration that makes evolutionary sense for an organism facing starvation or other stresses that also increase the risk of DNA damage.

One of the study’s most important findings concerns where in the animal DAF-16 operates. C. elegans contains two broadly distinct cellular compartments: the mitotic and meiotic germ cells that produce sperm and eggs, and the post-mitotic somatic cells that make up the body. The researchers determined that DAF-16 functions in both. In the soma, its activity supports the integrity of cells that can no longer divide and must simply endure damage for the remainder of the animal’s life. In the germline, its role is arguably even more critical, because the genome passed to the next generation must be protected from mutations that would become permanent heritable changes. The finding that a single nutrient-responsive transcription factor safeguards both compartments suggests that the insulin pathway coordinates genome maintenance across the entire organism rather than in a tissue-specific fashion.

The study then drilled down into the molecular fine print of DAF-16 itself. Like its mammalian FOXO cousins, DAF-16 exists as several protein isoforms generated by alternative splicing, each with slightly different sequence features and, presumably, different regulatory targets. When the team tested these isoforms individually, they discovered a clear division of labour: the DAF-16(d/f) isoform, but not the DAF-16(a) isoform, is essential for maintaining germline genome integrity. This isoform specificity is more than a technical curiosity. It implies that the different FOXO variants carved out by evolution are not interchangeable generalists but specialised tools, and it offers a potential explanation for why mammals maintain multiple FOXO genes with overlapping yet distinct functions in stress responses, metabolism and tumour suppression.

How, mechanically, does DAF-16 enhance the DNA damage response? The researchers found that the bulk of the enhancement flows through the canonical DDR components themselves, the conserved sensor and effector proteins such as the ATM-like kinases and the downstream repair pathways including homologous recombination and non-homologous end joining that mend double-strand breaks. By keeping the expression of these core components elevated, DAF-16 strengthens the primary repair machinery. Interestingly, however, the analysis revealed a secondary contribution from apoptosis, the programmed suicide of severely damaged cells. In the germline, cells whose genomes are too badly damaged to repair are normally eliminated as a failsafe, and DAF-16 activation appears to support this clearance pathway as well, albeit to a lesser extent than direct repair. Genome maintenance, in other words, is achieved through a two-pronged strategy: fix what can be fixed, and remove what cannot.

The evolutionary implications of the work are considerable. FOXO transcription factors are among the most conserved regulators of longevity known, operating in organisms from fruit flies to humans, and mammalian FOXO proteins have previously been implicated in DNA repair and tumour suppression. By establishing a direct, mechanistic role for DAF-16 in the DDR of C. elegans, the New Delhi team demonstrates that this function is conserved across the evolutionary divide separating worms and mammals. The study thus closes a conceptual loop in the biology of ageing: the same nutrient-sensing pathway that determines how long an animal lives also determines how faithfully its cells preserve the genetic instructions that make life possible in the first place. Longevity and genome stability, it turns out, are two faces of the same coin.

There are also practical horizons. Because reduced insulin/IGF signalling is a proven longevity intervention, and because DAF-16/FOXO sits at its downstream end, the new findings suggest that some of the health benefits of dampening insulin signalling may derive not from metabolic changes alone but from a strengthened capacity to repair DNA. In humans, where genomic instability underlies cancers, premature ageing syndromes and age-related tissue decline, understanding how FOXO activity could be tuned to bolster the DDR without unwanted side effects becomes an attractive pharmacological goal. The worm, with its transparent body, rapid life cycle and precisely mapped cell lineages, remains the ideal proving ground for such ideas.

For now, the study stands as a reminder that the molecules biologists thought they had categorised often harbour unexpected day jobs. DAF-16 earned its fame as a lifespan determinant, a switch that, when flipped by scarcity, extends life in the nematode. The new work shows that the same switch also keeps the genome intact under assault from radiation and other genotoxic insults, in both the cells of the body and the cells destined to become the next generation. In linking the insulin pathway, transcriptional regulation and the DNA damage response into a single coherent circuit, Devendran, Rautela, Sarkar, Mukhopadhyay and their colleagues have provided mechanistic insight into how an animal balances the energy demands of repair with the imperative of survival, and how evolution has wired the perception of nutrients directly into the defence of the genetic code itself.

Subject of Research: Role of DAF-16/FOXO in maintaining genome integrity through the DNA damage response in C. elegans

Article Title: DAF-16/FOXO maintains genome integrity following genotoxic stress

Article References: Devendran, O., Rautela, U., Sarkar, G. C., Ranjisha, K., Mittal, R., Bala, R., Goyala, A., & Mukhopadhyay, A. (2026). DAF-16/FOXO maintains genome integrity following genotoxic stress. BMC Biology. https://doi.org/10.1186/s12915-026-02755-9

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02755-9

Keywords: DAF-16, FOXO, DNA damage response, genome integrity, C. elegans, insulin/IGF signalling, DNA repair, germline, ageing, genotoxic stress, BMC Biology, maintains